| Product Code: ETC10815342 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Ireland saw a shift in small molecule CDMO import shipments with an increase in diversity as China, USA, Belgium, India, and Taiwan, Province of China emerged as the top exporting countries. The Herfindahl-Hirschman Index (HHI) indicated a transition from high to moderate concentration, reflecting a more balanced market landscape. Despite a challenging CAGR of -21.32% from 2020 to 2024, there was a steep decline in growth rate from 2023 to 2024 at -45.69%. This highlights the evolving dynamics and competitive environment within Ireland`s small molecule CDMO import market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Small Molecule CDMO Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Small Molecule CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Small Molecule CDMO Market - Industry Life Cycle |
3.4 Ireland Small Molecule CDMO Market - Porter's Five Forces |
3.5 Ireland Small Molecule CDMO Market Revenues & Volume Share, By Service Type, 2021 & 2031F |
3.6 Ireland Small Molecule CDMO Market Revenues & Volume Share, By API Type, 2021 & 2031F |
3.7 Ireland Small Molecule CDMO Market Revenues & Volume Share, By Drug Development Stage, 2021 & 2031F |
3.8 Ireland Small Molecule CDMO Market Revenues & Volume Share, By Facility Type, 2021 & 2031F |
3.9 Ireland Small Molecule CDMO Market Revenues & Volume Share, By Regulatory Compliance, 2021 & 2031F |
4 Ireland Small Molecule CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growth in pharmaceutical RD activities in Ireland |
4.2.2 Increasing outsourcing of drug manufacturing by pharmaceutical companies |
4.2.3 Favorable government policies supporting the biopharmaceutical industry in Ireland |
4.3 Market Restraints |
4.3.1 Intense competition in the small molecule CDMO market in Ireland |
4.3.2 Regulatory challenges and compliance requirements |
4.3.3 Fluctuations in raw material prices impacting production costs |
5 Ireland Small Molecule CDMO Market Trends |
6 Ireland Small Molecule CDMO Market, By Types |
6.1 Ireland Small Molecule CDMO Market, By Service Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Small Molecule CDMO Market Revenues & Volume, By Service Type, 2021 - 2031F |
6.1.3 Ireland Small Molecule CDMO Market Revenues & Volume, By Drug Substance Development, 2021 - 2031F |
6.1.4 Ireland Small Molecule CDMO Market Revenues & Volume, By Drug Product Manufacturing, 2021 - 2031F |
6.1.5 Ireland Small Molecule CDMO Market Revenues & Volume, By Formulation Services, 2021 - 2031F |
6.1.6 Ireland Small Molecule CDMO Market Revenues & Volume, By Analytical Testing, 2021 - 2031F |
6.1.7 Ireland Small Molecule CDMO Market Revenues & Volume, By Packaging & Logistics, 2021 - 2031F |
6.2 Ireland Small Molecule CDMO Market, By API Type |
6.2.1 Overview and Analysis |
6.2.2 Ireland Small Molecule CDMO Market Revenues & Volume, By Generic APIs, 2021 - 2031F |
6.2.3 Ireland Small Molecule CDMO Market Revenues & Volume, By Specialty APIs, 2021 - 2031F |
6.2.4 Ireland Small Molecule CDMO Market Revenues & Volume, By Biotech APIs, 2021 - 2031F |
6.2.5 Ireland Small Molecule CDMO Market Revenues & Volume, By Oncology Drug APIs, 2021 - 2031F |
6.2.6 Ireland Small Molecule CDMO Market Revenues & Volume, By High-Potency APIs, 2021 - 2031F |
6.3 Ireland Small Molecule CDMO Market, By Drug Development Stage |
6.3.1 Overview and Analysis |
6.3.2 Ireland Small Molecule CDMO Market Revenues & Volume, By Early-Stage Discovery, 2021 - 2031F |
6.3.3 Ireland Small Molecule CDMO Market Revenues & Volume, By Preclinical Trials, 2021 - 2031F |
6.3.4 Ireland Small Molecule CDMO Market Revenues & Volume, By Clinical Trials Phase 1, 2021 - 2031F |
6.3.5 Ireland Small Molecule CDMO Market Revenues & Volume, By Commercial Manufacturing, 2021 - 2031F |
6.3.6 Ireland Small Molecule CDMO Market Revenues & Volume, By Post- Surveillance, 2021 - 2031F |
6.4 Ireland Small Molecule CDMO Market, By Facility Type |
6.4.1 Overview and Analysis |
6.4.2 Ireland Small Molecule CDMO Market Revenues & Volume, By Pilot Scale, 2021 - 2031F |
6.4.3 Ireland Small Molecule CDMO Market Revenues & Volume, By Large-Scale Production, 2021 - 2031F |
6.4.4 Ireland Small Molecule CDMO Market Revenues & Volume, By R&D Facilities, 2021 - 2031F |
6.4.5 Ireland Small Molecule CDMO Market Revenues & Volume, By Sterile Manufacturing Units, 2021 - 2031F |
6.4.6 Ireland Small Molecule CDMO Market Revenues & Volume, By Integrated Supply Chain Management, 2021 - 2031F |
6.5 Ireland Small Molecule CDMO Market, By Regulatory Compliance |
6.5.1 Overview and Analysis |
6.5.2 Ireland Small Molecule CDMO Market Revenues & Volume, By US FDA & EMA Approved, 2021 - 2031F |
6.5.3 Ireland Small Molecule CDMO Market Revenues & Volume, By GMP & ISO 13485 Certified, 2021 - 2031F |
6.5.4 Ireland Small Molecule CDMO Market Revenues & Volume, By WHO GMP Standards, 2021 - 2031F |
6.5.5 Ireland Small Molecule CDMO Market Revenues & Volume, By Good Laboratory Practices, 2021 - 2031F |
6.5.6 Ireland Small Molecule CDMO Market Revenues & Volume, By Hazardous Material Handling, 2021 - 2031F |
7 Ireland Small Molecule CDMO Market Import-Export Trade Statistics |
7.1 Ireland Small Molecule CDMO Market Export to Major Countries |
7.2 Ireland Small Molecule CDMO Market Imports from Major Countries |
8 Ireland Small Molecule CDMO Market Key Performance Indicators |
8.1 Percentage of capacity utilization in small molecule CDMO facilities |
8.2 Number of new partnerships and collaborations within the industry |
8.3 Average project turnaround time for small molecule CDMO services |
9 Ireland Small Molecule CDMO Market - Opportunity Assessment |
9.1 Ireland Small Molecule CDMO Market Opportunity Assessment, By Service Type, 2021 & 2031F |
9.2 Ireland Small Molecule CDMO Market Opportunity Assessment, By API Type, 2021 & 2031F |
9.3 Ireland Small Molecule CDMO Market Opportunity Assessment, By Drug Development Stage, 2021 & 2031F |
9.4 Ireland Small Molecule CDMO Market Opportunity Assessment, By Facility Type, 2021 & 2031F |
9.5 Ireland Small Molecule CDMO Market Opportunity Assessment, By Regulatory Compliance, 2021 & 2031F |
10 Ireland Small Molecule CDMO Market - Competitive Landscape |
10.1 Ireland Small Molecule CDMO Market Revenue Share, By Companies, 2024 |
10.2 Ireland Small Molecule CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here